A citation-based method for searching scientific literature

Tetsuya Suhara, Yoshiro Okubo, Fumihiko Yasuno, Yasuhiko Sudo, Makoto Inoue, Tetsuya Ichimiya, Yoshifumi Nakashima, Kazuhiko Nakayama, Shuji Tanada, Kazutoshi Suzuki, Christer Halldin, Lars Farde. Arch Gen Psychiatry 2002
Times Cited: 133







List of co-cited articles
1139 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.
Mirjam Talvik, Anna-Lena Nordström, Hans Olsson, Christer Halldin, Lars Farde. Int J Neuropsychopharmacol 2003
91
50

D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.
Monte S Buchsbaum, Bradley T Christian, Douglas S Lehrer, Tanjore K Narayanan, Bingzhi Shi, Joseph Mantil, Eileen Kemether, Terrence R Oakes, Jogeshwar Mukherjee. Schizophr Res 2006
97
39

Extrastriatal dopamine D 2/3 receptor density and distribution in drug-naive schizophrenic patients.
H Tuppurainen, J Kuikka, H Viinamäki, M Husso-Saastamoinen, K Bergström, J Tiihonen. Mol Psychiatry 2003
46
78

Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia.
Fumihiko Yasuno, Tetsuya Suhara, Yoshiro Okubo, Yasuhiko Sudo, Makoto Inoue, Tetsuya Ichimiya, Akihiro Takano, Kazuhiko Nakayama, Christer Halldin, Lars Farde. Am J Psychiatry 2004
82
42

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
M Laruelle, A Abi-Dargham, C H van Dyck, R Gil, C D D'Souza, J Erdos, E McCance, W Rosenblatt, C Fingado, S S Zoghbi,[...]. Proc Natl Acad Sci U S A 1996
923
32

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
A Breier, T P Su, R Saunders, R E Carson, B S Kolachana, A de Bartolomeis, D R Weinberger, N Weisenfeld, A K Malhotra, W C Eckelman,[...]. Proc Natl Acad Sci U S A 1997
873
30

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
673
28

Prefrontal dopamine D1 receptors and working memory in schizophrenia.
Anissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, Roberto Gil, Diana Martinez, Yiyun Huang, Dah-Ren Hwang, John Keilp, Lisa Kochan, Ronald Van Heertum,[...]. J Neurosci 2002
500
27

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
D F Wong, H N Wagner, L E Tune, R F Dannals, G D Pearlson, J M Links, C A Tamminga, E P Broussolle, H T Ravert, A A Wilson,[...]. Science 1986
687
27

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
A Abi-Dargham, R Gil, J Krystal, R M Baldwin, J P Seibyl, M Bowers, C H van Dyck, D S Charney, R B Innis, M Laruelle. Am J Psychiatry 1998
561
25

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Y Okubo, T Suhara, K Suzuki, K Kobayashi, O Inoue, O Terasaki, Y Someya, T Sassa, Y Sudo, E Matsushima,[...]. Nature 1997
517
25

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, O Kirvelä, U Ruotsalainen. Lancet 1995
245
25

Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
Mirjam Talvik, Anna-Lena Nordström, Yoshiro Okubo, Hans Olsson, Jacqueline Borg, Christer Halldin, Lars Farde. Psychiatry Res 2006
54
46

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
L Farde, F A Wiesel, S Stone-Elander, C Halldin, A L Nordström, H Hall, G Sedvall. Arch Gen Psychiatry 1990
426
24

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.
Robert M Kessler, Neil D Woodward, Patrizia Riccardi, Rui Li, M Sib Ansari, Sharlett Anderson, Benoit Dawant, David Zald, Herbert Y Meltzer. Biol Psychiatry 2009
90
24

Increased dopamine transmission in schizophrenia: relationship to illness phases.
M Laruelle, A Abi-Dargham, R Gil, L Kegeles, R Innis. Biol Psychiatry 1999
495
21

Dopamine in schizophrenia: a review and reconceptualization.
K L Davis, R S Kahn, G Ko, M Davidson. Am J Psychiatry 1991
21

Elevated dopa decarboxylase activity in living brain of patients with psychosis.
J Reith, C Benkelfat, A Sherwin, Y Yasuhara, H Kuwabara, F Andermann, S Bachneff, P Cumming, M Diksic, S E Dyve,[...]. Proc Natl Acad Sci U S A 1994
239
21

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
L H Lindström, O Gefvert, G Hagberg, T Lundberg, M Bergström, P Hartvig, B Långström. Biol Psychiatry 1999
196
21


PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia.
Per Karlsson, Lars Farde, Christer Halldin, Göran Sedvall. Am J Psychiatry 2002
122
20

Frontal dopamine D(2/3) receptor binding in drug-naive first-episode schizophrenic patients correlates with positive psychotic symptoms and gender.
Birte Y Glenthoj, Torben Mackeprang, Claus Svarer, Hans Rasmussen, Lars H Pinborg, Lars Friberg, William Baaré, Ralf Hemmingsen, Charlotte Videbaek. Biol Psychiatry 2006
56
35


Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Andreas Meyer-Lindenberg, Robert S Miletich, Philip D Kohn, Giuseppe Esposito, Richard E Carson, Mario Quarantelli, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2002
453
18


Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, E Eronen,[...]. Schizophr Res 1999
176
18


Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
A L Nordström, L Farde, F A Wiesel, K Forslund, S Pauli, C Halldin, G Uppfeldt. Biol Psychiatry 1993
392
17

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
17


6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
A M Elkashef, D Doudet, T Bryant, R M Cohen, S H Li, R J Wyatt. Psychiatry Res 2000
75
22

Midbrain dopamine D2/3 receptor binding in schizophrenia.
Heli Tuppurainen, Jyrki T Kuikka, Mikko P Laakso, Heimo Viinamäki, Minna Husso, Jari Tiihonen. Eur Arch Psychiatry Clin Neurosci 2006
30
56

Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
C Halldin, L Farde, T Högberg, N Mohell, H Hall, T Suhara, P Karlsson, Y Nakashima, C G Swahn. J Nucl Med 1995
180
16


Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
A Laakso, H Vilkman, B Alakare, M Haaparanta, J Bergman, O Solin, J Peurasaari, V Räkköläinen, E Syvälahti, J Hietala. Am J Psychiatry 2000
92
17

Presynaptic dopaminergic function in the striatum of schizophrenic patients.
M H Dao-Castellana, M L Paillère-Martinot, P Hantraye, D Attar-Lévy, P Rémy, C Crouzel, E Artiges, A Féline, A Syrota, J L Martinot. Schizophr Res 1997
117
16

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Stephen McGowan, Andrew D Lawrence, Tim Sales, Digby Quested, Paul Grasby. Arch Gen Psychiatry 2004
149
16

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
Robert B Innis, Vincent J Cunningham, Jacques Delforge, Masahiro Fujita, Albert Gjedde, Roger N Gunn, James Holden, Sylvain Houle, Sung-Cheng Huang, Masanori Ichise,[...]. J Cereb Blood Flow Metab 2007
16

Simplified reference tissue model for PET receptor studies.
A A Lammertsma, S P Hume. Neuroimage 1996
15

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
J Hietala, E Syvälahti, K Vuorio, K Någren, P Lehikoinen, U Ruotsalainen, V Räkköläinen, V Lehtinen, U Wegelius. Arch Gen Psychiatry 1994
143
15

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
479
15

The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.
Ariel Graff-Guerrero, Romina Mizrahi, Ofer Agid, Heidi Marcon, Penny Barsoum, Pablo Rusjan, Alan A Wilson, Robert Zipursky, Shitij Kapur. Neuropsychopharmacology 2009
78
19

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
M Laruelle, A Abi-Dargham, C van Dyck, R Gil, D C D'Souza, J Krystal, J Seibyl, R Baldwin, R Innis. Biol Psychiatry 2000
107
14

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Ofer Agid, David Mamo, Nathalie Ginovart, Irina Vitcu, Alan A Wilson, Robert B Zipursky, Shitij Kapur. Neuropsychopharmacology 2007
90
15

The role of extrastriatal dopamine D2 receptors in schizophrenia.
Hidehiko Takahashi, Makoto Higuchi, Tetsuya Suhara. Biol Psychiatry 2006
54
25


Limbic selectivity of clozapine.
L S Pilowsky, R S Mulligan, P D Acton, P J Ell, D C Costa, R W Kerwin. Lancet 1997
127
13

Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET.
Tetsuya Suhara, Yasuhiko Sudo, Takashi Okauchi, Jun Maeda, Koichi Kawabe, Kazutoshi Suzuki, Yoshiro Okubo, Yoshifumi Nakashima, Hiroshi Ito, Shuji Tanada,[...]. Int J Neuropsychopharmacol 1999
85
15

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
Jogeshwar Mukherjee, Bradley T Christian, Kelly A Dunigan, Bingzhi Shi, Tanjore K Narayanan, Martin Satter, Joseph Mantil. Synapse 2002
183
13

Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
R M Kessler, W O Whetsell, M S Ansari, J R Votaw, T de Paulis, J A Clanton, D E Schmidt, N S Mason, R G Manning. Brain Res 1993
148
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.